CHYM · Stage, GEX levels and seasonality

Chime Financial, Inc. Class A Common Stock (CHYM)

Last close $33.55 (+1.57%) on 2026-11-13

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Open the chart

Weinstein stage

Stage 2B — Advancing (extended) · 12 weeks in this stage · 30-week average $25.25

Stage 2 (advancing): price holds above a rising 30-week average. The stage Weinstein buys.

What would change it: Stage 3 begins if the 30-week SMA (25.25) stops rising while price works around it, or after 3 straight weekly closes below it.

GEX levels

Call wall, put wall and gamma flip for CHYM are on Signa plans. What GEX levels tell you.

Seasonality

MonthAverage returnMonths upYears
January-3.71%0%1
February-12.94%0%1
March-13.06%0%1
April+15.59%100%1
May-16.37%0%1
June+12.2%100%1
July+7.17%100%2
August+13.89%50%2
September-20.13%0%2
October-7.58%50%2
November (this month)+23.06%100%1
December+24.94%100%1

Based on up to 2 years of weekly closes. Past seasonality does not predict future returns.

On Signa plans

The Signa score and Action Card for CHYM, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Questions about CHYM

What Weinstein stage is CHYM in?

CHYM is in Stage 2B — Advancing (extended), for 12 weeks, based on completed weekly bars and its 30-week moving average (25.25).

How has CHYM done in November?

Over the last 1 year, CHYM averaged +23.06% in November and rose in 100% of them. Past seasonality does not predict future returns.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.